These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 18293232)
1. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232 [TBL] [Abstract][Full Text] [Related]
2. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797 [TBL] [Abstract][Full Text] [Related]
3. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117 [TBL] [Abstract][Full Text] [Related]
4. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903 [TBL] [Abstract][Full Text] [Related]
5. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B; Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390 [TBL] [Abstract][Full Text] [Related]
6. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977 [TBL] [Abstract][Full Text] [Related]
7. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Haug NA; Sorensen JL; Gruber VA; Lollo N; Roth G Behav Modif; 2006 Nov; 30(6):752-81. PubMed ID: 17050764 [TBL] [Abstract][Full Text] [Related]
8. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Spire B; Lucas GM; Carrieri MP Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374 [TBL] [Abstract][Full Text] [Related]
9. Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users. Wood E; Kerr T; Hogg RS; Palepu A; Zhang R; Strathdee SA; Montaner JS Drug Alcohol Rev; 2006 Sep; 25(5):451-4. PubMed ID: 16939941 [TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill. Delgado J; Heath KV; Yip B; Marion S; Alfonso V; Montaner JS; O'Shaughnessy MV; Hogg RS Antivir Ther; 2003 Oct; 8(5):471-8. PubMed ID: 14640395 [TBL] [Abstract][Full Text] [Related]
11. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam. Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958 [TBL] [Abstract][Full Text] [Related]
12. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs. Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317 [TBL] [Abstract][Full Text] [Related]
13. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275 [TBL] [Abstract][Full Text] [Related]
14. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. Small W; Wood E; Betteridge G; Montaner J; Kerr T AIDS Care; 2009 Jun; 21(6):708-14. PubMed ID: 19806487 [TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Shuter J; Bernstein SL Nicotine Tob Res; 2008 Apr; 10(4):731-6. PubMed ID: 18418794 [TBL] [Abstract][Full Text] [Related]
16. Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle-aged women. Santoro N; Arnsten JH; Buono D; Howard AA; Schoenbaum EE J Womens Health (Larchmt); 2005 Dec; 14(10):898-905. PubMed ID: 16372891 [TBL] [Abstract][Full Text] [Related]
17. A review of barriers and facilitators of HIV treatment among injection drug users. Wood E; Kerr T; Tyndall MW; Montaner JS AIDS; 2008 Jul; 22(11):1247-56. PubMed ID: 18580603 [TBL] [Abstract][Full Text] [Related]
18. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. Vaz MJ; Barros SM; Palacios R; Senise JF; Lunardi L; Amed AM; Castelo A Int J STD AIDS; 2007 Jan; 18(1):28-32. PubMed ID: 17326859 [TBL] [Abstract][Full Text] [Related]
19. Validity of self-reported adherence among injection drug users. Kerr T; Hogg RS; Yip B; Tyndall MW; Montaner J; Wood E J Int Assoc Physicians AIDS Care (Chic); 2008; 7(4):157-9. PubMed ID: 18626123 [TBL] [Abstract][Full Text] [Related]
20. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Ware NC; Wyatt MA; Tugenberg T Soc Sci Med; 2005 Aug; 61(3):565-76. PubMed ID: 15899316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]